🇺🇸 FDA
Patent

US 12018011

Macrocyclic compounds and compositions, and methods of preparing and using the same

granted A61PA61P35/00

Quick answer

US patent 12018011 (Macrocyclic compounds and compositions, and methods of preparing and using the same) held by Kura Oncology, Inc. expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kura Oncology, Inc.
Grant date
Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
222
CPC classes
A61P, A61P35/00